CC
ONCS

Caxton Corporation’s OncoSec Medical Incorporated ONCS Stock Holding History

Caxton Corporation’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,270
Closed -$449K – 66
2021
Q2 		$449K Buy
7,270
+2,003
+38% +$182K 0.31% 43
2021
Q1 		$553K Buy
+5,267
New +$721K 0.36% 24

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caxton Corporation's ONCS Position: Q3 2021 in Review

Caxton Corporation sold out of OncoSec Medical Incorporated (ONCS) in Q3 2021, closing a stake of 7,270 shares — an estimated $449K sold.

Caxton Corporation first reported a position in ONCS in Q1 2021 and held it in 2 quarters. The position peaked at $553K in Q1 2021. 31 funds tracked by Wall St. Rank hold ONCS as of Q3 2021.

  • Caxton Corporation reported no remaining OncoSec Medical Incorporated position as of Q3 2021 after selling out during the quarter.
  • Caxton Corporation sold 7,270 OncoSec Medical Incorporated shares in Q3 2021, an estimated $449K.
  • Caxton Corporation first reported a position in OncoSec Medical Incorporated in Q1 2021 and held it in 2 quarters.
  • Caxton Corporation's OncoSec Medical Incorporated position peaked at $553K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2021.

Based on Caxton Corporation's 13F filing for Q3 2021, filed 15 Nov 2021.